Home / CANCER BUZZ Podcast

CANCER BUZZ Podcast

Want the latest BUZZ? Just listen in!

The CANCER BUZZ podcast features fresh perspectives on hot topics in oncology care delivery. CANCER BUZZ is where stakeholders from the front lines of care to the C-suite, from research to the registry, from chairside to benchside, talk about top-of-mind questions and real-world impact.

Listen to the CANCER BUZZ podcast on Apple Podcasts, Spotify, Amazon Music, or wherever you get your podcasts. You can now listen with your smart home device. For instructions on how to listen with Alexa, click here, or just tell Alexa to "Play CANCER BUZZ." For Google Home instructions, click here.

Filter By Topic

Clear filter

Filter By Podcast Format

 
 
 
 
 
    Displaying results 1 - 20 of 30
  • 1
  • 2
  • »
Live this week from the ACCC 51st Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ shares insights from ACCC President Nadine J. Barrett, PhD, MA, MS, and ASCO President Robin Zon, MD, FASCO, FACP, on challenges in cancer care, leadership strategies, AI, and more.
Live this week from the ACCC 51st Annual Meeting and Cancer Center Business Summit (AMCCBS), CANCER BUZZ highlights ACCC President Nadine J. Barrett, PhD, MA, MS, on her tenure as ACCC’s 2024-2025 President.
Bladder cancer remains a prevalent disease with significant disparities in care, particularly in underserved populations. To address this, ACCC launched a national quality improvement initiative in three phases: 1. assessment and preparation, 2. action plan implementation, and 3. monitoring for continuous improvement. Dr. Samuel Washington, from the University of California, San Francisco, discussed …
The imPROVE study aims to bridge the gap in patient-reported outcomes (PRO) data for Black women with breast cancer by enhancing engagement with tailored electronic PROs (ePROs) and partnering with community leaders to address barriers and ensure accessibility and relevance in community cancer care settings. In this episode, CANCER BUZZ speaks with Manraj Kaur, PhD, investigator and lead faculty …
As a large country, economic disparities persist as a public health issue in Brazil, with 70% of the population depending on the public health system. According to Dr. Theodora Karnakis, the aging population of patients with cancer is expected to result in a 61% increase of new cancer cases between 2020 and 2040. The type of care received depends heavily on where patients are located, due to the varying …
Immunotherapy and targeted therapies have transformed the way patients are treated and allow more patients than ever before to survive stage IV diagnoses. Other key advancements in oncology being prioritized in Puerto Rico today include early detection and prevention efforts. However, a lack of education, access, and health insurance coverage often prevents community members from timely cancer …
All health systems work with limited resources to some degree. The challenge faced across the globe is finding the best way to allocate those resources to help the patient population as much as possible.
CANCERBUZZ speaks with Dr. Naoto Ueno about his NOC session titled The Hawaiʻi Cancer Consortium: An Equitable Clinical Trials Initiative.
CANCERBUZZ speaks with Melanie Grant about her NOC session titled Navigating Access and Equity: Providing the Answers That Matter.
CANCERBUZZ speaks with ACCC’s Immediate Past President Dr. Olalekan Ajayi about the international panel held at NOC this year, where cancer care providers from around the world share and learn from common challenges and best practices.
CANCERBUZZ speaks with Magbis Nunez Love about her NOC session titled Renacer: Culturally Tailored, Patient-Centered Survivorship Care Improves Access and Outcomes.
Designing a health equity playbook starts with a deep understanding of the patients you serve. Successful playbooks have components that build on the patient experience, the protocols that are in place to ensure the cancer program is meeting the unique needs of all its patients, and staff education and and training on how to best serve those different patient populations.
Social determinants of health have been proven to impact access to care, but further delineation is necessary to describe their effect on treatment selection itself. To mitigate this knowledge gap, the Association of Cancer Care Centers (ACCC) sought to identify the impact that social determinants of health may have on guideline-concordant treatment selection in hormone receptor positive, HER2 …
Hear from a pharmacist and an oncology operations manager as they share how the digital Patient Assistance Guide tool can help you find resources in less time so patients can access—and better afford—their cancer treatments.
Hear from two authors of an ACCC/LUNGevity Foundation study that identified key areas of clinician need related to biomarker testing in NSCLC.
In this episode, we'll hear the evolution of the advanced practitioners (APs) role at her institution, where APs have a larger voice in the research process and clinical trial protocols, serve as champions to advocate for patients and research staff, and collaborate with their team to promote best practices in clinical trial delivery.
A physician and administrator champion at Cone Health Cancer Center share why it’s more important than ever to make transportation assistance services available to patients with cancer.
In this episode, we'll explore how oncology advanced practitioners (APs) can play a greater role in clinical research and, according to a recent national study, have a strong interest in doing so.
In this episode, Colleen Lewis, MSN, ANP-BC, AOCNP, talks about the critical role oncology advanced practitioners can play in moving the needle on equity and inclusion in cancer clinical trials.
Learn about the cultural and logistical barriers to end-of-life health equity and discover strategies that programs can implement to both address palliative care earlier in the care continuum and reduce health disparities.
    Displaying results 1 - 20 of 30
  • 1
  • 2
  • »
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Community Cancer Centers.